Polymorphic Aldehyde Scavenger Compounds
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for treating, preventing, and reducing the risk of diseases or disorders where aldehyde toxicity is implicated in the pathogenesis, as current methods lack effective solutions for scavenging toxic aldehydes such as malondialdehyde (MDA) and 4-hydroxyl-2-nonenal (4HNE).
Innovation Solution
Compounds represented by a specific chemical structure, in various salt forms or freebase forms, are used to treat and prevent conditions associated with aldehyde toxicity, including dry eye, cataracts, keratoconus, and other ocular and non-ocular disorders, by scavenging toxic aldehydes and reducing their harmful effects.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If small molecule therapeutics are used to scavenge toxic aldehydes, then aldehyde toxicity is reduced and disease progression is slowed, but the compounds must be designed to achieve optimal scavenging efficiency and safety profile
Solution Approach 1:
The patent applies parameter changes by systematically varying chemical parameters of the scavenger compounds, including substituent groups (R1-R6), functional groups (e.g., hydroxyl, carboxyl, amino), and molecular weight ranges (50-500 Da). This allows optimization of scavenging efficiency and safety profiles for different aldehyde toxicities without requiring complex multi-component systems.
2Reliability
If polymorphic forms of the compounds are provided, then bioavailability and pharmacokinetic properties are improved, but additional characterization and validation work is required
Solution Approach 1:
The patent applies phase transitions by providing multiple polymorphic forms (crystalline forms) of the scavenger compounds. Different polymorphic forms are obtained through controlled crystallization processes, which improve bioavailability and pharmacokinetic properties. The patent characterizes these forms using X-ray diffraction, NMR, and thermal analysis to ensure consistent quality and performance.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The compounds effectively scavenge toxic aldehydes, thereby ameliorating symptoms and slowing the progression of associated pathological conditions, providing a pharmaceutical solution for conditions like Age-Related Macular Degeneration, skin disorders, and neurodegenerative diseases.
Implementation Method 1
small molecule therapeutics acting as a scavenger for toxic aldehydes
Data Source
AI summary
The present invention provides freebase and salt forms, and compositions and methods thereof, useful for treating various conditions in which aldehyde toxicity is implicated in the pathogenesis by the administration of small molecule therapeutics acting as a scavenger for toxic aldehydes.